Clinical Resources

Seattle Heart Failure Model

1, 2, and 3-Year Mortality Prediction in Heart Failure

Age (years)

years

Sex

Male Female

NYHA Class

I II III IV

Weight (kg)

kg

Systolic BP (mmHg)

mmHg

LVEF (%)

%

Ischemic Etiology

Yes No

Sodium (mEq/L)

mEq/L

Hemoglobin (g/dL)

g/dL

Lymphocytes (%) — optional

%

Uric Acid (mg/dL) — optional

mg/dL

Total Cholesterol (mg/dL) — optional

mg/dL

Loop Diuretic Dose (furosemide equiv. mg/day)

mg/d

Medications

ACE inhibitor or ARB

Beta-blocker

Aldosterone antagonistSpironolactone or eplerenone

Statin

Allopurinol

Digoxin

Loop diuretics

Results

Linear Predictor —

1-Year Mortality —

2-Year Mortality —

3-Year Mortality —

Risk Category —

Enter patient data above.

Reference

Levy WC et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation. 2006;113(11):1424-1433.